Showing Results for
- Academic Journals (5,631)
Search Results
- 5,631
Academic Journals
- 5,631
-
From:Avicenna Journal of Medical Biotechnology (Vol. 5, Issue 1) Peer-ReviewedIran has taken significant steps in the fields of animal cloning, stem cell therapy and recombinant protein drugs in the past decade. The cloning of animals, stem cell therapies and transplantation by the Iranian stem...
-
From:Journal of Commercial Biotechnology (Vol. 19, Issue 3) Peer-ReviewedThis paper examines the roles of culture in the principles of biomedical ethics. Drawing on examples from African, Navajo and Western cultures, the paper maintains that various elements of culture are indispensable to...
-
From:Nature Biotechnology (Vol. 32, Issue 2) Peer-ReviewedThomas C. Reynolds has been elected to the board of directors of Oxford BioTherapeutics (Oxford, UK and San Jose, CA, USA). Reynolds has over 20 years of biotech industry experience, most recently serving as chief...
-
From:Nature (Vol. 505, Issue 7486) Peer-ReviewedPanama has joined a handful of nations trying to combat dengue fever using genetically modified mosquitoes developed by Oxitec, a biotechnology firm in Oxford, UK (see go.nature. com/tht55x). The company announced on 28...
-
From:Nature Biotechnology (Vol. 32, Issue 5) Peer-ReviewedTo the Editor: Much has been written about rocketing biotech stock prices and the opening of public markets to biotech companies over the past 18 months. But access to public funding brings with it substantial costs...
-
From:Nature Biotechnology (Vol. 32, Issue 11) Peer-ReviewedKane Biotech (Winnipeg, Manitoba, Canada) has named Mark Nawacki to its board of directors, replacing Richard Cherney who is retiring from the board. Nawacki is a co-managing partner of Davies Ward Phillips & Vineberg....
-
From:Nature Biotechnology (Vol. 29, Issue 10) Peer-ReviewedImmunovaccine (Halifax, Nova Scotia, Canada) has appointed John J. Trizzino as CEO and a member of the board. He joins Immunovaccine from Novavax, where he served as senior vice president....
-
From:Nature (Vol. 463, Issue 7280) Peer-ReviewedGene company reboots: Two months after filing for bankruptcy, the 14-year-old genomics company deCODE Genetics, based in Reykjavik, has been resurrected as a newly financed private company. Research will be headed by...
-
From:Nature Biotechnology (Vol. 28, Issue 9) Peer-ReviewedInvida Group (Singapore) has announced that it has added three new members to its senior management team: Sumeet Sud has been named to the newly created role of chief marketing officer, and Girdhar Balwani and Thomas...
-
From:Nature Biotechnology (Vol. 28, Issue 1) Peer-ReviewedPepscan Holding (Lelystad, The Netherlands) has appointed Wim E.M. Mol as CEO. He brings more than 20 years of experience in the pharma industry, most recently at Schering Plough where he was vice president responsible...
-
From:Pharmaceutical Technology Europe (Vol. 22, Issue 12) Peer-ReviewedBiotech has had a profound impact on the pharma industry by helping to develop new medicines that treat patients more effectively; however, despite its achievements, it hasn't made a significant difference to the number...
-
From:Pharmaceutical Technology Europe (Vol. 21, Issue 1) Peer-ReviewedA European initiative hopes to unite research, industrial and training resources in the biotech and medtech sectors by creating the 'Alps Bio Cluster' over an extended transalpine area. The partners involved in the...
-
From:Nature (Vol. 457, Issue 7229) Peer-ReviewedTECHNOLOGY FEATURE: GLYCOBIOLOGY COMPANY PRODUCTS/ACTIVITY LOCATION Glycobiology companies Dextra Laboratories Monosaccharides, glycoconjugates Reading, UK and N-linked oligosaccharides GlycoFi Engineered yeast strains...
-
From:Avicenna Journal of Medical Biotechnology (Vol. 1, Issue 2) Peer-ReviewedIn this study, an attempt has been made to expound the Iranian law of intellectual property in relation to biotechnology. The most important themes studied are patents, industrial designs and trade marks. The latest...
-
From:Formulary (Vol. 43, Issue 10) Peer-ReviewedCustirsen (OGX-011, OncoGenex) in combination with docetaxel for the treatment of progressive metastatic prostate cancer...
-
From:Formulary (Vol. 43, Issue 8) Peer-Reviewed* Ustekinumab (Centocor) for the treatment of moderate-to-severe plaque psoriasis in adults...
-
From:Pharmaceutical Technology Europe (Vol. 20, Issue 8) Peer-ReviewedAustralia Australian self-Medication Industry Inc. Level 22, 141 Walker Street PO BOX 764 (2059) North Sydney NSW 2060 Tel. +61 29922 5111 Fax +61 29959 3693 info@asmi.com.au www.asmi.com.au...
-
From:The Scientist (Vol. 19, Issue 12) Peer-ReviewedAfter months of missed deadlines, the US Food and Drug Administration this March finally released its Guidance for Industry on when and how drug companies should submit genomics data, and how the agency will evaluate...
-
From:Regenerative Medicine (Vol. 1, Issue 5)Author(s): Chris Mason [[dagger]] 1 , Mike Hoare 1 Here, we first examine whether lessons may be learned for autologous cell processing from other fields addressing personalized targets. We then summarize how...
-
From:Pharmaceutical Technology Europe (Vol. 18, Issue 5) Peer-ReviewedThe British drug development company Inpharmatica has announced a collaboration with American firm Ingenuity Systems. The pair are to share their independently-developed drug discovery tools. Inpharmatica will bring its...